Stories of GLP-1 drugs like Ozempic, Wegovy, Zepbound, and Mounjaro reducing patients’ desire to drink alcohol have been showing up everywhere. Now a new study in Nature Communications finds a 50-56% decrease in the risk of new or recurring alcohol addictions
Thank you for bringing this study to my attention. I have been interested in this subject. Here is some of what I put together on it. It will be very interesting to see when the RCTs start to come in.
Thank you for bringing this study to my attention. I have been interested in this subject. Here is some of what I put together on it. It will be very interesting to see when the RCTs start to come in.
https://sobersynthesis.com/2024/04/03/glp-1-agonists-role-in-addiction/
Thanks Jeff and great piece
Thanks so much for your work. So glad to see this getting attention.
Thank you!